| | | | | |
GHRS GH Research PLC Ordinary Shares | €19,2576 | -3,28% | €1,27B | €117,86K | |
GBX The Greenbrier Companies, Inc. | €41,7510 | +0,50% | €1,27B | €44,02K | |
| €33,6815 | +2,94% | €1,27B | €72,83K | |
QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund - Shares of Beneficial Interest | €26,6201 | -0,10% | €1,27B | €33,89K | |
CBL CBL & Associates Properties, Inc. | €40,5537 | -0,08% | €1,27B | €250,66K | |
| €6,4206 | +1,43% | €1,26B | €5,38M | |
MBX MBX Biosciences, Inc. Common Stock | €27,9576 | +2,38% | €1,26B | €216,47K | |
URGN UroGen Pharma Ltd. Ordinary Shares | €25,3041 | -0,14% | €1,26B | €221,79K | |
| €24,0622 | -2,89% | €1,26B | €365,29K | |
NVGS NAVIGATOR HOLDINGS LTD. | €19,4856 | -2,81% | €1,26B | €158,19K | |
CMPS COMPASS Pathways Plc American Depository Shares | €10,1389 | -3,57% | €1,26B | €1,74M | |
| €40,8135 | -1,47% | €1,25B | €43,71K | |
ARI APOLLO COMMERCIAL REAL ESTATE FINANCE, INC. | €9,4310 | -0,68% | €1,25B | €711,78K | |
| €8,7859 | +0,05% | €1,25B | €736,12K | |
| €32,1540 | +0,28% | €1,25B | €92,11K | |
